APO Research
Talk to an analyst

APO RESEARCH · REPORT

Erythropoietin Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Erythropoietin Drugs Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchErythropoietin Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Erythropoietin Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Erythropoietin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Erythropoietin Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Erythropoietin Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Erythropoietin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Erythropoietin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Erythropoietin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Erythropoietin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Erythropoietin Drugs include Johnson & Johnson, Roche, Amgen, LG Life Sciences, Kyowa Hakko Kirin, Galenica, Emcure, Biocon and 3SBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Erythropoietin Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Erythropoietin Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Erythropoietin Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Erythropoietin Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Erythropoietin Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Erythropoietin Drugs Market by Company

Johnson & Johnson

Roche

Amgen

LG Life Sciences

Kyowa Hakko Kirin

Galenica

Emcure

Biocon

3SBio

Erythropoietin Drugs Segment by Type

Epoetin-alfa

Darbepoetin-alfa

Epoetin-beta

Others

Erythropoietin Drugs Segment by Application

Anemia

Kidney Disorders

Others

Erythropoietin Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erythropoietin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Erythropoietin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erythropoietin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Erythropoietin Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Erythropoietin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Epoetin-alfa Table 2. Major Company of Darbepoetin-alfa Table 3. Major Company of Epoetin-beta Table 4. Major Company of Others Table 5. Global Erythropoietin Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs) Table 7. Global Erythropoietin Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Erythropoietin Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Erythropoietin Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Erythropoietin Drugs Price by Type (2021-2026) & (US$/Pcs) Table 11. Global Erythropoietin Drugs Sales by Type (2027-2032) & (K Pcs) Table 12. Global Erythropoietin Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Erythropoietin Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Erythropoietin Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Erythropoietin Drugs Price by Type (2027-2032) & (US$/Pcs) Table 16. North America Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs) Table 17. North America Erythropoietin Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs) Table 19. Europe Erythropoietin Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs) Table 21. Asia-Pacific Erythropoietin Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs) Table 23. Latin America Erythropoietin Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs) Table 25. Middle East and Africa Erythropoietin Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Erythropoietin Drugs Industry Trends Table 27. Erythropoietin Drugs Industry Drivers Table 28. Erythropoietin Drugs Industry Opportunities and Challenges Table 29. Erythropoietin Drugs Industry Restraints Table 30. Global Erythropoietin Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Erythropoietin Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Erythropoietin Drugs Sales by Company (2021-2026) & (K Pcs) Table 33. Global Erythropoietin Drugs Sales Share by Company (2021-2026) Table 34. Global Erythropoietin Drugs Market Price by Company (2021-2026) & (US$/Pcs) Table 35. Global Erythropoietin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Erythropoietin Drugs Major Company Production Sites and Headquarters Table 37. Global Erythropoietin Drugs Company, Product Type & Application Table 38. Global Erythropoietin Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Erythropoietin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Erythropoietin Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Erythropoietin Drugs Sales by Region (2021-2026) & (K Pcs) Table 43. Global Erythropoietin Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Erythropoietin Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Erythropoietin Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Erythropoietin Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 47. Global Erythropoietin Drugs Sales by Region (2027-2032) & (K Pcs) Table 48. Global Erythropoietin Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Erythropoietin Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Erythropoietin Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Erythropoietin Drugs Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 52. Global Erythropoietin Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs) Table 54. Global Erythropoietin Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Erythropoietin Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Erythropoietin Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Erythropoietin Drugs Price by Application (2021-2026) & (US$/Pcs) Table 58. Global Erythropoietin Drugs Sales by Application (2027-2032) & (K Pcs) Table 59. Global Erythropoietin Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Erythropoietin Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Erythropoietin Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Erythropoietin Drugs Price by Application (2027-2032) & (US$/Pcs) Table 63. North America Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs) Table 64. North America Erythropoietin Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs) Table 66. Europe Erythropoietin Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs) Table 68. Asia-Pacific Erythropoietin Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs) Table 70. Latin America Erythropoietin Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs) Table 72. Middle East and Africa Erythropoietin Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Erythropoietin Drugs Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 81. Roche Erythropoietin Drugs Product Portfolio Table 82. Roche Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 86. Amgen Erythropoietin Drugs Product Portfolio Table 87. Amgen Recent Development Table 88. LG Life Sciences Company Information Table 89. LG Life Sciences Business Overview Table 90. LG Life Sciences Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 91. LG Life Sciences Erythropoietin Drugs Product Portfolio Table 92. LG Life Sciences Recent Development Table 93. Kyowa Hakko Kirin Company Information Table 94. Kyowa Hakko Kirin Business Overview Table 95. Kyowa Hakko Kirin Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 96. Kyowa Hakko Kirin Erythropoietin Drugs Product Portfolio Table 97. Kyowa Hakko Kirin Recent Development Table 98. Galenica Company Information Table 99. Galenica Business Overview Table 100. Galenica Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 101. Galenica Erythropoietin Drugs Product Portfolio Table 102. Galenica Recent Development Table 103. Emcure Company Information Table 104. Emcure Business Overview Table 105. Emcure Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 106. Emcure Erythropoietin Drugs Product Portfolio Table 107. Emcure Recent Development Table 108. Biocon Company Information Table 109. Biocon Business Overview Table 110. Biocon Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 111. Biocon Erythropoietin Drugs Product Portfolio Table 112. Biocon Recent Development Table 113. 3SBio Company Information Table 114. 3SBio Business Overview Table 115. 3SBio Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 116. 3SBio Erythropoietin Drugs Product Portfolio Table 117. 3SBio Recent Development Table 118. North America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 119. North America Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs) Table 120. North America Erythropoietin Drugs Sales Market Share by Country (2021-2026) Table 121. North America Erythropoietin Drugs Sales Forecast by Country (2027-2032) & (K Pcs) Table 122. North America Erythropoietin Drugs Sales Market Share Forecast by Country (2027-2032) Table 123. North America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Erythropoietin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Erythropoietin Drugs Market Share by Country (2021-2026) Table 126. North America Erythropoietin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Erythropoietin Drugs Market Share Forecast by Country (2027-2032) Table 128. Europe Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 129. Europe Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs) Table 130. Europe Erythropoietin Drugs Sales Market Share by Country (2021-2026) Table 131. Europe Erythropoietin Drugs Sales Forecast by Country (2027-2032) & (K Pcs) Table 132. Europe Erythropoietin Drugs Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Erythropoietin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Erythropoietin Drugs Market Share by Country (2021-2026) Table 136. Europe Erythropoietin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Erythropoietin Drugs Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs) Table 140. Asia-Pacific Erythropoietin Drugs Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Erythropoietin Drugs Sales Forecast by Country (2027-2032) & (K Pcs) Table 142. Asia-Pacific Erythropoietin Drugs Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Erythropoietin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Erythropoietin Drugs Market Share by Country (2021-2026) Table 146. Asia-Pacific Erythropoietin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Erythropoietin Drugs Market Share Forecast by Country (2027-2032) Table 148. Latin America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 149. Latin America Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs) Table 150. Latin America Erythropoietin Drugs Sales Market Share by Country (2021-2026) Table 151. Latin America Erythropoietin Drugs Sales Forecast by Country (2027-2032) & (K Pcs) Table 152. Latin America Erythropoietin Drugs Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Erythropoietin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Erythropoietin Drugs Market Share by Country (2021-2026) Table 156. Latin America Erythropoietin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Erythropoietin Drugs Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs) Table 160. Middle East and Africa Erythropoietin Drugs Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Erythropoietin Drugs Sales Forecast by Country (2027-2032) & (K Pcs) Table 162. Middle East and Africa Erythropoietin Drugs Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Erythropoietin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Erythropoietin Drugs Market Share by Country (2021-2026) Table 166. Middle East and Africa Erythropoietin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Erythropoietin Drugs Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Erythropoietin Drugs Distributors List Table 171. Erythropoietin Drugs Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Erythropoietin Drugs Image Figure 2. Global Erythropoietin Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Erythropoietin Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Erythropoietin Drugs Sales (2021-2032) & (K Pcs) Figure 5. Epoetin-alfa Image Figure 6. Global Epoetin-alfa Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. Darbepoetin-alfa Image Figure 8. Global Darbepoetin-alfa Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Epoetin-beta Image Figure 10. Global Epoetin-beta Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 13. Global Erythropoietin Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Erythropoietin Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Erythropoietin Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Erythropoietin Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Erythropoietin Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Erythropoietin Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Erythropoietin Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Erythropoietin Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Erythropoietin Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Erythropoietin Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Erythropoietin Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Erythropoietin Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Erythropoietin Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Anemia Image Figure 28. Global Anemia Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Kidney Disorders Image Figure 30. Global Kidney Disorders Sales YoY Growth (2021-2032) & (K Pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 33. Global Erythropoietin Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Erythropoietin Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Erythropoietin Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Erythropoietin Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Erythropoietin Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Erythropoietin Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Erythropoietin Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Erythropoietin Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Erythropoietin Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Erythropoietin Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Erythropoietin Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Erythropoietin Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Erythropoietin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. North America Erythropoietin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Erythropoietin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Erythropoietin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Erythropoietin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Europe Erythropoietin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Erythropoietin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Erythropoietin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Erythropoietin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Asia-Pacific Erythropoietin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Erythropoietin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Erythropoietin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Erythropoietin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Latin America Erythropoietin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Erythropoietin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Erythropoietin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Erythropoietin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 62. Middle East and Africa Erythropoietin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Erythropoietin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Erythropoietin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Erythropoietin Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Erythropoietin Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Epoetin-alfa
  • Darbepoetin-alfa
  • Epoetin-beta
  • Others
Applications
  • Anemia
  • Kidney Disorders
  • Others
Companies covered
  • Johnson & Johnson
  • Roche
  • Amgen
  • LG Life Sciences
  • Kyowa Hakko Kirin
  • Galenica
  • Emcure
  • Biocon
  • 3SBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Erythropoietin Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Erythropoietin Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Erythropoietin Drugs Market by Type
  6. 1.3.1 Epoetin-alfa
  7. 1.3.2 Darbepoetin-alfa
  8. 1.3.3 Epoetin-beta
  9. 1.3.4 Others
  10. 1.4 Global Erythropoietin Drugs Market Size by Type
  11. 1.4.1 Global Erythropoietin Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Erythropoietin Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Erythropoietin Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Erythropoietin Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Erythropoietin Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Erythropoietin Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Erythropoietin Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Erythropoietin Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Erythropoietin Drugs Industry Trends
  2. 2.2 Erythropoietin Drugs Industry Drivers
  3. 2.3 Erythropoietin Drugs Industry Opportunities and Challenges
  4. 2.4 Erythropoietin Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Erythropoietin Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Erythropoietin Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Erythropoietin Drugs Price (2021-2026)
  4. 3.4 Global Erythropoietin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Erythropoietin Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Erythropoietin Drugs Company, Product Type & Application
  7. 3.7 Global Erythropoietin Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Erythropoietin Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Erythropoietin Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Erythropoietin Drugs Tier 1, Tier 2, and Tier 3
4 Erythropoietin Drugs Regional Status and Outlook
  1. 4.1 Global Erythropoietin Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Erythropoietin Drugs Historic Market Size by Region
  3. 4.2.1 Global Erythropoietin Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Erythropoietin Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Erythropoietin Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Erythropoietin Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Erythropoietin Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Erythropoietin Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Erythropoietin Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Erythropoietin Drugs by Application
  1. 5.1 Erythropoietin Drugs Market by Application
  2. 5.1.1 Anemia
  3. 5.1.2 Kidney Disorders
  4. 5.1.3 Others
  5. 5.2 Global Erythropoietin Drugs Market Size by Application
  6. 5.2.1 Global Erythropoietin Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Erythropoietin Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Erythropoietin Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Erythropoietin Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Erythropoietin Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Erythropoietin Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Erythropoietin Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Erythropoietin Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Erythropoietin Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Erythropoietin Drugs Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Erythropoietin Drugs Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 LG Life Sciences
  20. 6.4.1 LG Life Sciences Company Information
  21. 6.4.2 LG Life Sciences Business Overview
  22. 6.4.3 LG Life Sciences Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LG Life Sciences Erythropoietin Drugs Product Portfolio
  24. 6.4.5 LG Life Sciences Recent Developments
  25. 6.5 Kyowa Hakko Kirin
  26. 6.5.1 Kyowa Hakko Kirin Company Information
  27. 6.5.2 Kyowa Hakko Kirin Business Overview
  28. 6.5.3 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kyowa Hakko Kirin Erythropoietin Drugs Product Portfolio
  30. 6.5.5 Kyowa Hakko Kirin Recent Developments
  31. 6.6 Galenica
  32. 6.6.1 Galenica Company Information
  33. 6.6.2 Galenica Business Overview
  34. 6.6.3 Galenica Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Galenica Erythropoietin Drugs Product Portfolio
  36. 6.6.5 Galenica Recent Developments
  37. 6.7 Emcure
  38. 6.7.1 Emcure Company Information
  39. 6.7.2 Emcure Business Overview
  40. 6.7.3 Emcure Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Emcure Erythropoietin Drugs Product Portfolio
  42. 6.7.5 Emcure Recent Developments
  43. 6.8 Biocon
  44. 6.8.1 Biocon Company Information
  45. 6.8.2 Biocon Business Overview
  46. 6.8.3 Biocon Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biocon Erythropoietin Drugs Product Portfolio
  48. 6.8.5 Biocon Recent Developments
  49. 6.9 3SBio
  50. 6.9.1 3SBio Company Information
  51. 6.9.2 3SBio Business Overview
  52. 6.9.3 3SBio Erythropoietin Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 3SBio Erythropoietin Drugs Product Portfolio
  54. 6.9.5 3SBio Recent Developments
7 North America by Country
  1. 7.1 North America Erythropoietin Drugs Sales by Country
  2. 7.1.1 North America Erythropoietin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Erythropoietin Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Erythropoietin Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Erythropoietin Drugs Market Size by Country
  6. 7.2.1 North America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Erythropoietin Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Erythropoietin Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Erythropoietin Drugs Sales by Country
  2. 8.1.1 Europe Erythropoietin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Erythropoietin Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Erythropoietin Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Erythropoietin Drugs Market Size by Country
  6. 8.2.1 Europe Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Erythropoietin Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Erythropoietin Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Erythropoietin Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Erythropoietin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Erythropoietin Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Erythropoietin Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Erythropoietin Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Erythropoietin Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Erythropoietin Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Erythropoietin Drugs Sales by Country
  2. 10.1.1 South America Erythropoietin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Erythropoietin Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Erythropoietin Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Erythropoietin Drugs Market Size by Country
  6. 10.2.1 South America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Erythropoietin Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Erythropoietin Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Erythropoietin Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Erythropoietin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Erythropoietin Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Erythropoietin Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Erythropoietin Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Erythropoietin Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Erythropoietin Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Erythropoietin Drugs Value Chain Analysis
  2. 12.1.1 Erythropoietin Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Erythropoietin Drugs Production Mode & Process
  7. 12.2 Erythropoietin Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Erythropoietin Drugs Distributors
  10. 12.2.3 Erythropoietin Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst